ArticlePCN reports : psychiatry and clinical neurosciences2025
Characteristics linked to mortality risk among individuals with drug use disorders enrolled in drug rehabilitation facilities in Japan.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Peer support and 2-year abstinence in alcohol use disorder: A nationwide prospective cohort study in recovery-support facilities.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Characteristics linked to mortality risk among individuals with drug use disorders enrolled in drug rehabilitation facilities in Japan.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study evaluated survival rates and examined characteristics associated with mortality among individuals with drug use disorder (DUD) enrolled in drug addiction rehabilitation facilities in Japan. Methods: This longitudinal cohort study, conducted from October 2016 to October 2021, followed 361 individuals with DUD residing in drug addiction rehabilitation centers nationwide. Participants had a mean age of 41.1 years (standard deviation 9.7) and most were men. About half had not completed high school or had criminal records, including drug offenses. Data were collected through eight follow-up assessments conducted approximately every 6 months. Kaplan-Meier analysis was used to calculate 5-year survival rates, and age-specific mortality was evaluated among participants. A Cox proportional hazards model identified characteristics influencing mortality risk, including demographic factors, medical history, and abstinence maintenance. Hazard ratios and 95% confidence intervals were calculated to assess mortality risk. Results: The survival rate was 95.4%, with 14 deaths recorded. Mortality was highest among participants aged over 60 years. Age and the presence of bloodborne or sexually transmitted infections were significantly associated with higher mortality, while abstinence was associated with reduced mortality. Conclusion: This study is the first to examine survival rates and mortality factors among individuals with DUD in drug addiction recovery centers in Japan. Findings suggest that these facilities may help prevent drug relapses and reduce mortality risk, while highlighting aging and infections as key factors linked to mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.